89Bio Inc reports results for the quarter ended in March - Earnings Summary

89bio

09/05/2023 13:00

* 89Bio Inc  ETNB.OQ  reported a quarterly adjusted loss
of 54
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 52
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * 89Bio Inc's reported EPS for the quarter was a loss of 54
cents​.
    * The mean earnings estimate of analysts had risen by
about 14.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * 89Bio Inc shares had risen by 14.2% this quarter and
gained 36.7% so far this year.
    * The company reported a quarterly loss of $28.84 million.
    * Wall Street's median 12-month price target for 89Bio Inc
is
$33.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 12:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.52          -0.54          Missed
 Dec. 31 2022      -0.69          -0.48          Beat
 Sep. 30 2022      -0.80          -0.57          Beat
 Jun. 30 2022      -1.05          -1.23          Missed